Foundation for Sarcoidosis Research Warns of Increased Risk of Sarcoidosis from Fire and Smoke Exposure Urging Immediate Action to Prevent Future Health Consequences 9/11 First Responders Serve as a Warning for the Long-Term Health Effects of Smoke Inhalation and...
We understand that living with sarcoidosis can be challenging, and many of you are constantly seeking new treatment options. We want to share an important update regarding recently announced results from a pulmonary sarcoidosis clinical trial. Key Points: Trial...
The Foundation for Sarcoidosis Research (FSR) is proud to announce the recipients of the 2024 FSR Cardiac Sarcoidosis Grant, providing $200,000 in funding to advance groundbreaking research aimed at improving the diagnosis, management, and treatment of cardiac...
In August of 2023, the Foundation for Sarcoidosis Research (FSR) submitted a Request for Opinion Letter on Clinical Trials and the Family and Medical Leave Act (FMLA) with the U.S. Department of Labor (DOL). On November 8, 2024, FSR received a letter of clarification...
